Safety and activity of RRx-001 in patients with advanced cancer: A first-in-human, open-label, dose-escalation phase 1 study

Tony Reid, Bryan Oronsky, Jan Scicinski, Curt L. Scribner, Susan J. Knox, Shoucheng Ning, Donna M. Peehl, Ron Korn, Meaghan Stirn, Corey A. Carter, Arnold Oronsky, Michael J. Taylor, William L. Fitch, Pedro Cabrales, Michelle M. Kim, Howard A. Burris, Christopher D. Lao, Nacer E.D. Abrouk, Gary R. Fanger, Jeffrey R. Infante